 | • レポートコード：MRC2-11QY02817 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腋窩多汗症薬のグローバル市場について調査・分析したレポートです。種類別（ボツリヌス毒素A、グリコピロレート、トシレートグリコピロニウム、その他）市場規模、用途別（クリニック、病院、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腋窩多汗症薬の競争状況、市場シェア ・世界の腋窩多汗症薬市場：種類別市場規模 2015年-2020年（ボツリヌス毒素A、グリコピロレート、トシレートグリコピロニウム、その他） ・世界の腋窩多汗症薬市場：種類別市場規模予測 2021年-2026年（ボツリヌス毒素A、グリコピロレート、トシレートグリコピロニウム、その他） ・世界の腋窩多汗症薬市場：用途別市場規模 2015年-2020年（クリニック、病院、在宅ケア） ・世界の腋窩多汗症薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、在宅ケア） ・北米の腋窩多汗症薬市場分析：米国、カナダ ・ヨーロッパの腋窩多汗症薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腋窩多汗症薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腋窩多汗症薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腋窩多汗症薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan Plc、Brickell Biotech Inc、Dermira Inc、Dr. August Wolff GmbH & Co KG Arzneimittle、GlaxoSmithKline Plc、TheraVida Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Axillary Hyperhidrosis Drug Market
The global Axillary Hyperhidrosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Axillary Hyperhidrosis Drug Scope and Market Size
Axillary Hyperhidrosis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Axillary Hyperhidrosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Axillary Hyperhidrosis Drug market is segmented into
Botulinum ToxinA
Glycopyrrolate
Glycopyrronium Tosylate
Others
Segment by Application, the Axillary Hyperhidrosis Drug market is segmented into
Clinic
Hospital
Home Care
Regional and Country-level Analysis
The Axillary Hyperhidrosis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Axillary Hyperhidrosis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Axillary Hyperhidrosis Drug Market Share Analysis
Axillary Hyperhidrosis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Axillary Hyperhidrosis Drug business, the date to enter into the Axillary Hyperhidrosis Drug market, Axillary Hyperhidrosis Drug product introduction, recent developments, etc.
The major vendors covered:
Allergan Plc
Brickell Biotech Inc
Dermira Inc
Dr. August Wolff GmbH & Co KG Arzneimittle
GlaxoSmithKline Plc
TheraVida Inc
…
1 Study Coverage
1.1 Axillary Hyperhidrosis Drug Product Introduction
1.2 Market Segments
1.3 Key Axillary Hyperhidrosis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Type
1.4.2 Botulinum ToxinA
1.4.3 Glycopyrrolate
1.4.4 Glycopyrronium Tosylate
1.4.5 Others
1.5 Market by Application
1.5.1 Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Axillary Hyperhidrosis Drug Market Size, Estimates and Forecasts
2.1.1 Global Axillary Hyperhidrosis Drug Revenue 2015-2026
2.1.2 Global Axillary Hyperhidrosis Drug Sales 2015-2026
2.2 Global Axillary Hyperhidrosis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Axillary Hyperhidrosis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Axillary Hyperhidrosis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Axillary Hyperhidrosis Drug Competitor Landscape by Players
3.1 Axillary Hyperhidrosis Drug Sales by Manufacturers
3.1.1 Axillary Hyperhidrosis Drug Sales by Manufacturers (2015-2020)
3.1.2 Axillary Hyperhidrosis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Axillary Hyperhidrosis Drug Revenue by Manufacturers
3.2.1 Axillary Hyperhidrosis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Axillary Hyperhidrosis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Axillary Hyperhidrosis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Axillary Hyperhidrosis Drug Revenue in 2019
3.2.5 Global Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Axillary Hyperhidrosis Drug Price by Manufacturers
3.4 Axillary Hyperhidrosis Drug Manufacturing Base Distribution, Product Types
3.4.1 Axillary Hyperhidrosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Axillary Hyperhidrosis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Axillary Hyperhidrosis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Axillary Hyperhidrosis Drug Market Size by Type (2015-2020)
4.1.1 Global Axillary Hyperhidrosis Drug Sales by Type (2015-2020)
4.1.2 Global Axillary Hyperhidrosis Drug Revenue by Type (2015-2020)
4.1.3 Axillary Hyperhidrosis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Axillary Hyperhidrosis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Axillary Hyperhidrosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Axillary Hyperhidrosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Axillary Hyperhidrosis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Axillary Hyperhidrosis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Axillary Hyperhidrosis Drug Market Size by Application (2015-2020)
5.1.1 Global Axillary Hyperhidrosis Drug Sales by Application (2015-2020)
5.1.2 Global Axillary Hyperhidrosis Drug Revenue by Application (2015-2020)
5.1.3 Axillary Hyperhidrosis Drug Price by Application (2015-2020)
5.2 Axillary Hyperhidrosis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Axillary Hyperhidrosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Axillary Hyperhidrosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Axillary Hyperhidrosis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Axillary Hyperhidrosis Drug by Country
6.1.1 North America Axillary Hyperhidrosis Drug Sales by Country
6.1.2 North America Axillary Hyperhidrosis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Axillary Hyperhidrosis Drug Market Facts & Figures by Type
6.3 North America Axillary Hyperhidrosis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Axillary Hyperhidrosis Drug by Country
7.1.1 Europe Axillary Hyperhidrosis Drug Sales by Country
7.1.2 Europe Axillary Hyperhidrosis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Axillary Hyperhidrosis Drug Market Facts & Figures by Type
7.3 Europe Axillary Hyperhidrosis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Axillary Hyperhidrosis Drug by Region
8.1.1 Asia Pacific Axillary Hyperhidrosis Drug Sales by Region
8.1.2 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Axillary Hyperhidrosis Drug Market Facts & Figures by Type
8.3 Asia Pacific Axillary Hyperhidrosis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Axillary Hyperhidrosis Drug by Country
9.1.1 Latin America Axillary Hyperhidrosis Drug Sales by Country
9.1.2 Latin America Axillary Hyperhidrosis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Axillary Hyperhidrosis Drug Market Facts & Figures by Type
9.3 Central & South America Axillary Hyperhidrosis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Axillary Hyperhidrosis Drug by Country
10.1.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country
10.1.2 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Axillary Hyperhidrosis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Axillary Hyperhidrosis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Corporation Information
11.1.2 Allergan Plc Description and Business Overview
11.1.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Plc Axillary Hyperhidrosis Drug Products Offered
11.1.5 Allergan Plc Related Developments
11.2 Brickell Biotech Inc
11.2.1 Brickell Biotech Inc Corporation Information
11.2.2 Brickell Biotech Inc Description and Business Overview
11.2.3 Brickell Biotech Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Products Offered
11.2.5 Brickell Biotech Inc Related Developments
11.3 Dermira Inc
11.3.1 Dermira Inc Corporation Information
11.3.2 Dermira Inc Description and Business Overview
11.3.3 Dermira Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Dermira Inc Axillary Hyperhidrosis Drug Products Offered
11.3.5 Dermira Inc Related Developments
11.4 Dr. August Wolff GmbH & Co KG Arzneimittle
11.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Corporation Information
11.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Description and Business Overview
11.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Products Offered
11.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Related Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Corporation Information
11.5.2 GlaxoSmithKline Plc Description and Business Overview
11.5.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Products Offered
11.5.5 GlaxoSmithKline Plc Related Developments
11.6 TheraVida Inc
11.6.1 TheraVida Inc Corporation Information
11.6.2 TheraVida Inc Description and Business Overview
11.6.3 TheraVida Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 TheraVida Inc Axillary Hyperhidrosis Drug Products Offered
11.6.5 TheraVida Inc Related Developments
11.1 Allergan Plc
11.1.1 Allergan Plc Corporation Information
11.1.2 Allergan Plc Description and Business Overview
11.1.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Plc Axillary Hyperhidrosis Drug Products Offered
11.1.5 Allergan Plc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Axillary Hyperhidrosis Drug Market Estimates and Projections by Region
12.1.1 Global Axillary Hyperhidrosis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Axillary Hyperhidrosis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Axillary Hyperhidrosis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Axillary Hyperhidrosis Drug Sales Forecast (2021-2026)
12.2.2 North America: Axillary Hyperhidrosis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Axillary Hyperhidrosis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Axillary Hyperhidrosis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Axillary Hyperhidrosis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Axillary Hyperhidrosis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Axillary Hyperhidrosis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Axillary Hyperhidrosis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Axillary Hyperhidrosis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Axillary Hyperhidrosis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Axillary Hyperhidrosis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Axillary Hyperhidrosis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Axillary Hyperhidrosis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Axillary Hyperhidrosis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Axillary Hyperhidrosis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Axillary Hyperhidrosis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Axillary Hyperhidrosis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Axillary Hyperhidrosis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Axillary Hyperhidrosis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Axillary Hyperhidrosis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Axillary Hyperhidrosis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Axillary Hyperhidrosis Drug Market Segments
Table 2. Ranking of Global Top Axillary Hyperhidrosis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Botulinum ToxinA
Table 5. Major Manufacturers of Glycopyrrolate
Table 6. Major Manufacturers of Glycopyrronium Tosylate
Table 7. Major Manufacturers of Others
Table 8. Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Axillary Hyperhidrosis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Axillary Hyperhidrosis Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Axillary Hyperhidrosis Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Axillary Hyperhidrosis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Axillary Hyperhidrosis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Axillary Hyperhidrosis Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Axillary Hyperhidrosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Axillary Hyperhidrosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Axillary Hyperhidrosis Drug as of 2019)
Table 17. Axillary Hyperhidrosis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Axillary Hyperhidrosis Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Axillary Hyperhidrosis Drug Price (2015-2020) (USD/Pcs)
Table 20. Axillary Hyperhidrosis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Axillary Hyperhidrosis Drug Product Type
Table 22. Date of International Manufacturers Enter into Axillary Hyperhidrosis Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Axillary Hyperhidrosis Drug Sales by Type (2015-2020) (K Pcs)
Table 25. Global Axillary Hyperhidrosis Drug Sales Share by Type (2015-2020)
Table 26. Global Axillary Hyperhidrosis Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Axillary Hyperhidrosis Drug Revenue Share by Type (2015-2020)
Table 28. Axillary Hyperhidrosis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Axillary Hyperhidrosis Drug Sales by Application (2015-2020) (K Pcs)
Table 30. Global Axillary Hyperhidrosis Drug Sales Share by Application (2015-2020)
Table 31. North America Axillary Hyperhidrosis Drug Sales by Country (2015-2020) (K Pcs)
Table 32. North America Axillary Hyperhidrosis Drug Sales Market Share by Country (2015-2020)
Table 33. North America Axillary Hyperhidrosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Axillary Hyperhidrosis Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Axillary Hyperhidrosis Drug Sales by Type (2015-2020) (K Pcs)
Table 36. North America Axillary Hyperhidrosis Drug Sales Market Share by Type (2015-2020)
Table 37. North America Axillary Hyperhidrosis Drug Sales by Application (2015-2020) (K Pcs)
Table 38. North America Axillary Hyperhidrosis Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Axillary Hyperhidrosis Drug Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Axillary Hyperhidrosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Axillary Hyperhidrosis Drug Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Axillary Hyperhidrosis Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Axillary Hyperhidrosis Drug Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Axillary Hyperhidrosis Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Axillary Hyperhidrosis Drug Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Axillary Hyperhidrosis Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Axillary Hyperhidrosis Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Axillary Hyperhidrosis Drug Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Axillary Hyperhidrosis Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Axillary Hyperhidrosis Drug Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Axillary Hyperhidrosis Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Axillary Hyperhidrosis Drug Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Axillary Hyperhidrosis Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Axillary Hyperhidrosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Axillary Hyperhidrosis Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Axillary Hyperhidrosis Drug Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Axillary Hyperhidrosis Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Axillary Hyperhidrosis Drug Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Axillary Hyperhidrosis Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Axillary Hyperhidrosis Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Application (2015-2020)
Table 71. Allergan Plc Corporation Information
Table 72. Allergan Plc Description and Major Businesses
Table 73. Allergan Plc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Allergan Plc Product
Table 75. Allergan Plc Recent Development
Table 76. Brickell Biotech Inc Corporation Information
Table 77. Brickell Biotech Inc Description and Major Businesses
Table 78. Brickell Biotech Inc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Brickell Biotech Inc Product
Table 80. Brickell Biotech Inc Recent Development
Table 81. Dermira Inc Corporation Information
Table 82. Dermira Inc Description and Major Businesses
Table 83. Dermira Inc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Dermira Inc Product
Table 85. Dermira Inc Recent Development
Table 86. Dr. August Wolff GmbH & Co KG Arzneimittle Corporation Information
Table 87. Dr. August Wolff GmbH & Co KG Arzneimittle Description and Major Businesses
Table 88. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Dr. August Wolff GmbH & Co KG Arzneimittle Product
Table 90. Dr. August Wolff GmbH & Co KG Arzneimittle Recent Development
Table 91. GlaxoSmithKline Plc Corporation Information
Table 92. GlaxoSmithKline Plc Description and Major Businesses
Table 93. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline Plc Product
Table 95. GlaxoSmithKline Plc Recent Development
Table 96. TheraVida Inc Corporation Information
Table 97. TheraVida Inc Description and Major Businesses
Table 98. TheraVida Inc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. TheraVida Inc Product
Table 100. TheraVida Inc Recent Development
Table 101. Global Axillary Hyperhidrosis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 102. Global Axillary Hyperhidrosis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Axillary Hyperhidrosis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Axillary Hyperhidrosis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Axillary Hyperhidrosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 106. North America: Axillary Hyperhidrosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Axillary Hyperhidrosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Europe: Axillary Hyperhidrosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Axillary Hyperhidrosis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 110. Asia Pacific: Axillary Hyperhidrosis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Axillary Hyperhidrosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. Latin America: Axillary Hyperhidrosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Axillary Hyperhidrosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Middle East and Africa: Axillary Hyperhidrosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Axillary Hyperhidrosis Drug Players
Table 119. Axillary Hyperhidrosis Drug Customers List
Table 120. Axillary Hyperhidrosis Drug Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Axillary Hyperhidrosis Drug Product Picture
Figure 2. Global Axillary Hyperhidrosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Botulinum ToxinA Product Picture
Figure 4. Glycopyrrolate Product Picture
Figure 5. Glycopyrronium Tosylate Product Picture
Figure 6. Others Product Picture
Figure 7. Global Axillary Hyperhidrosis Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Home Care
Figure 11. Axillary Hyperhidrosis Drug Report Years Considered
Figure 12. Global Axillary Hyperhidrosis Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Axillary Hyperhidrosis Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Axillary Hyperhidrosis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Axillary Hyperhidrosis Drug Sales Market Share by Region in 2019
Figure 17. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region in 2019
Figure 19. Global Axillary Hyperhidrosis Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Axillary Hyperhidrosis Drug Revenue in 2019
Figure 21. Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Axillary Hyperhidrosis Drug Sales Market Share by Type in 2019
Figure 24. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type in 2019
Figure 26. Global Axillary Hyperhidrosis Drug Market Share by Price Range (2015-2020)
Figure 27. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Axillary Hyperhidrosis Drug Sales Market Share by Application in 2019
Figure 29. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application in 2019
Figure 31. North America Axillary Hyperhidrosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Axillary Hyperhidrosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Axillary Hyperhidrosis Drug Sales Market Share by Country in 2019
Figure 34. North America Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Axillary Hyperhidrosis Drug Market Share by Type in 2019
Figure 40. North America Axillary Hyperhidrosis Drug Market Share by Application in 2019
Figure 41. Europe Axillary Hyperhidrosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Axillary Hyperhidrosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country in 2019
Figure 44. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2019
Figure 45. Germany Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Axillary Hyperhidrosis Drug Market Share by Type in 2019
Figure 56. Europe Axillary Hyperhidrosis Drug Market Share by Application in 2019
Figure 57. Asia Pacific Axillary Hyperhidrosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Axillary Hyperhidrosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Axillary Hyperhidrosis Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Axillary Hyperhidrosis Drug Revenue Market Share by Region in 2019
Figure 61. China Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Axillary Hyperhidrosis Drug Market Share by Type in 2019
Figure 84. Asia Pacific Axillary Hyperhidrosis Drug Market Share by Application in 2019
Figure 85. Latin America Axillary Hyperhidrosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Axillary Hyperhidrosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Axillary Hyperhidrosis Drug Sales Market Share by Country in 2019
Figure 88. Latin America Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Axillary Hyperhidrosis Drug Market Share by Type in 2019
Figure 96. Latin America Axillary Hyperhidrosis Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Axillary Hyperhidrosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Axillary Hyperhidrosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Axillary Hyperhidrosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Axillary Hyperhidrosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Axillary Hyperhidrosis Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Axillary Hyperhidrosis Drug Market Share by Application in 2019
Figure 109. North America Axillary Hyperhidrosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Axillary Hyperhidrosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Axillary Hyperhidrosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Axillary Hyperhidrosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Axillary Hyperhidrosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…- 家庭用乱用薬物検査の世界市場（～2026年） The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers. The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the l…
- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…
- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…
- 注射可能型ドラッグデリバリーの世界市場（～2026年） Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body. North Amer…